For intra-articular delivery of chondroitin sulfate

Glycobiology

Volumn 19, Issue 8, 2009, Pages 813-815

  David Raoudi, M ^a   Mendichi, R ^b   Pujol, Jean Pierre ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b Istituto Nazionale per lo Studio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE; CHONDROITIN SULFATE; COLLAGENASE 3; CYCLOOXYGENASE 2; DIACETYLRHEIN; GLUCOSAMINE SULFATE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; NUTRACEUTICAL; PIASCLEDINE; PLACEBO; POLYSACCHARIDE; PROSTAGLANDIN E2; PROTEOGLYCAN; REACTIVE OXYGEN METABOLITE; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTICULAR CARTILAGE; BONE METABOLISM; CARTILAGE CELL; CARTILAGE MATRIX; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG SYNTHESIS; FIBROBLAST; HUMAN; HYDRATION; MAXIMUM PLASMA CONCENTRATION; MOLECULAR WEIGHT; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OSTEOARTHRITIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SINGLE DRUG DOSE; SYNOVIAL FLUID; SYNOVIOCYTE; TISSUE REPAIR; UPREGULATION;

CARTILAGE, ARTICULAR; CHONDROITIN SULFATES; HUMANS; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS;

EID: 67650102332     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwp069     Document Type: Article

References (23)

1. Adebowale AO, Cox DS, Liang Z, Eddington ND. 2000. Analysis of glucosamine and chondroitin sulfate content in marketed products and the Caco-2 permeability of chondroitin sulfate raw materials. J Am Nutraceutical Assoc. 3:37-44.
2. Baici A, Hörler D, Moser B, Hofer HO, Feher K, Wagenhaüser FJ. 1992. Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate. Rheumatol Int. 12:81-88.
3. Barnhill JG, Fye CL, Williams DW, Reda DJ, Harris CL, Clegg DO. 2006. Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial. J Am Pharm Assoc. 46:14-24.
4. Bassleer CT, Combal JPA, Bougaret S, Malaise M. 1998. Effects of chondroitin sulfate and interleukin-1β on human articular chondrocytes cultivated in clusters. Osteoarthritis Cartilage. 6:196-204.
5. Chan PS, Caron JP, Orth MW. 2005. Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular explants. Am J Vet Res. 66:1870-1876.
6. 2 in articular cartilage explants. Osteoarthritis Cartilage. 13:387-394.
7. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO 3rd, Weisman MH, Jackson CG, et al. 2006. Glucosamine, Chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 354:795-808.
8. David-Raoudi M, Deschrevel B, Leclercq S, Galéra P, Boumediene P, Pujol JP. 2009. Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases. Role of p38 and Akt. Arthritis Rheum. 60:760-770.
9. Hui JH, Chan S-W, Li J. 2007. Intra-articular delivery of chondroitin sulfate for the treatment of joint defects in rabbit model. J Mol Hist. 38:483-489.
10. Kydd AS, Reno CR, Tsao HW, Hart DA. 2007. Early inflammatory arthritis in the rabbit: The influence of intraarticular and systemic corticosteroids on mRNA levels in connective tissue of the knee. J Rheumatol. 34:130-139.
11. Lamari FN. 2008. The potential of chondroitin sulfate as a therapeutic agent. Connect Tissue Res. 49:289-292.
12. Legendre F, Baugé C, Roche R, Saurel AS, Pujol JP. 2008. Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1β-stimulated chondrocytes - Study in hypoxic alginate bead cultures. Osteoarthritis Cartilage. 16:105-114.
13. Malawaki CJ, Asimakopoulou AP, Lamari FN, Theocharis AD, Tzanakakis G, Karamanos NK. 2007. Capillary electrophoresis for the quality control of chondroitin sulfates in raw materials and formulations. Anal Biochem 374:213-220.
14. Montfort J, Nacher M, Montell E, Vila J, Verges J, Benito P. 2005. Chondroitin sulfate and hyaluronic acid (500-730 kDa) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes. Drug Exp Clin Res. 31:71-76.
15. Morreale P, Manopulo R, Galati M, Boccanera L, Saponati G, Bocchi L. 1996. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol. 23:1385-1391.
16. Ronca F, Palmieri L, Panicucci P, Ronca G. 1998. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage. 6:14-21.
17. Saad OM, Myers RA, Castleton DL, Leary JA. 2005. Analysis of hyaluronan content in chondroitin sulfate preparations by using selective enzymatic digestion and electrospray ionization mass spectrometry. Anal Biochem 344:232-239.
18. Sakai S, Onose J, Nakamura N, Toyoda H, Toida T, Imanari T, et al. 2002. Pretreatment procedure for the microdetermination of chondroitin sulfate in plasma and urine. Anal Biochem. 302:169-174.
19. Silbert JE. 2009. Dietary glucosamine under question. Glycobiology 19:564-667.
20. Sim JS, Jun G, Toida T, Cho SY, Choi DW, Chang SY, Linhardt RJ, Kim YS. 2005. Quantitative analysis of chondroitin sulphate in raw materials, ophthalmic solutions, soft capsules and liquid preparations. J Chromatogr B Analyt Technol Biomed Life Sci. 818:133-139.
21. Uebelhart D, Knols R, de Bruin ED, Verbruggen G. 2006. Chondroitin sulfate as a structure-modifying agent. Ad Pharmacol. 53:475-488.
22. Verbruggen G, Veys EM. 1977. Influence of sulphated glycosaminoglycans upon proteoglycan metabolism of the synovial lining cells. Acta Rhumatol Belg. 1:75-92.
23. Yasuda T. 2007. Hyaluronan inhibits cytokine production by lipopolysaccharide-stimulated U937 macrophages through down-regulation of NF-κB via ICAM-1. Inflamm Res. 56:246-253.